These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 12198535)

  • 1. Cognitive change and the APOE epsilon 4 allele.
    Deary IJ; Whiteman MC; Pattie A; Starr JM; Hayward C; Wright AF; Carothers A; Whalley LJ
    Nature; 2002 Aug; 418(6901):932. PubMed ID: 12198535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E and cognitive performance: a meta-analysis.
    Small BJ; Rosnick CB; Fratiglioni L; Bäckman L
    Psychol Aging; 2004 Dec; 19(4):592-600. PubMed ID: 15584785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dementia and cognitive impairment pattern: its association with epsilon4 allele of apolipoprotein E gene].
    Rosich-Estragó M; Figuera-Terré L; Mulet-Pérez B; Arrufat-Cardús MT; Pascual San Emeterio A; Arbeola-Rigau I; Labad-Alquézar A; Vilella-Cuadrada E
    Rev Neurol; 2004 May 1-15; 38(9):801-7. PubMed ID: 15152345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Context-specific memory and apolipoprotein E (ApoE) epsilon 4: cognitive evidence from the NIMH prospective study of risk for Alzheimer's disease.
    Levy JA; Bergeson J; Putnam K; Rosen V; Cohen R; Lalonde F; Mirza N; Linker G; Sunderland T
    J Int Neuropsychol Soc; 2004 May; 10(3):362-70. PubMed ID: 15147594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOE genotype influences functional status among elderly without dementia.
    Albert SM; Gurland B; Maestre G; Jacobs DM; Stern Y; Mayeux R
    Am J Med Genet; 1995 Dec; 60(6):583-7. PubMed ID: 8825902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
    Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
    Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive impairment in Alzheimer's disease is modified by APOE genotype.
    van der Vlies AE; Pijnenburg YA; Koene T; Klein M; Kok A; Scheltens P; van der Flier WM
    Dement Geriatr Cogn Disord; 2007; 24(2):98-103. PubMed ID: 17596691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.
    Martins CA; Oulhaj A; de Jager CA; Williams JH
    Neurology; 2005 Dec; 65(12):1888-93. PubMed ID: 16380608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain-derived neurotrophic factor, apolipoprotein E genetic variants and cognitive performance in Alzheimer's disease.
    Nacmias B; Piccini C; Bagnoli S; Tedde A; Cellini E; Bracco L; Sorbi S
    Neurosci Lett; 2004 Sep; 367(3):379-83. PubMed ID: 15337270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive asymmetries associated with apolipoprotein E genotype in patients with Alzheimer's disease.
    Finton MJ; Lucas JA; Rippeth JD; Bohac DL; Smith GE; Ivnik RJ; Petersen RC; Graff-Radford NR
    J Int Neuropsychol Soc; 2003 Jul; 9(5):751-9. PubMed ID: 12901781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of apolipoprotein E and cognitive function in old age.
    Mooijaart SP; van Vliet P; van Heemst D; Rensen PC; Berbée JF; Jolles J; de Craen AJ; Westendorp RG
    Ann N Y Acad Sci; 2007 Apr; 1100():148-61. PubMed ID: 17460173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of apolipoprotein E alleles on cognitive performance and dynamic neural activity over six decades.
    Alexander DM; Williams LM; Gatt JM; Dobson-Stone C; Kuan SA; Todd EG; Schofield PR; Cooper NJ; Gordon E
    Biol Psychol; 2007 Jul; 75(3):229-38. PubMed ID: 17433528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Middle-aged children of persons with Alzheimer's disease: APOE genotypes and cognitive function in the Wisconsin Registry for Alzheimer's Prevention.
    Sager MA; Hermann B; La Rue A
    J Geriatr Psychiatry Neurol; 2005 Dec; 18(4):245-9. PubMed ID: 16306248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age and apolipoprotein E*4 allele effects on cerebrospinal fluid beta-amyloid 42 in adults with normal cognition.
    Peskind ER; Li G; Shofer J; Quinn JF; Kaye JA; Clark CM; Farlow MR; DeCarli C; Raskind MA; Schellenberg GD; Lee VM; Galasko DR
    Arch Neurol; 2006 Jul; 63(7):936-9. PubMed ID: 16831961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
    Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K
    Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E epsilon4 allele and lorazepam effects on memory in high-functioning older adults.
    Pomara N; Willoughby L; Wesnes K; Greenblatt DJ; Sidtis JJ
    Arch Gen Psychiatry; 2005 Feb; 62(2):209-16. PubMed ID: 15699298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E, cardiovascular disease and cognitive function in aging women.
    Kang JH; Logroscino G; De Vivo I; Hunter D; Grodstein F
    Neurobiol Aging; 2005 Apr; 26(4):475-84. PubMed ID: 15653176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern and progression of cognitive decline in Alzheimer's disease: role of premorbid intelligence and ApoE genotype.
    Bracco L; Piccini C; Baccini M; Bessi V; Biancucci F; Nacmias B; Bagnoli S; Sorbi S
    Dement Geriatr Cogn Disord; 2007; 24(6):483-91. PubMed ID: 18025782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
    Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
    Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APOE alleles in Parkinson disease and their relationship to cognitive decline: a population-based, longitudinal study.
    Kurz MW; Dekomien G; Nilsen OB; Larsen JP; Aarsland D; Alves G
    J Geriatr Psychiatry Neurol; 2009 Sep; 22(3):166-70. PubMed ID: 19321880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.